Stockscreener 앱 받기
1,038.40
0.53%
5.43
Lilly Eli Co 주식(LLY)의 최신 뉴스
Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus - MSN
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? - The Motley Fool
Eli Lilly Shares Face Pressure Following Regulatory Setback - AD HOC NEWS
Eli Lilly stock price in focus as FDA slips obesity pill deadline — what to watch in LLY next week - TechStock²
This pharmaceutical executive has Trump's ear - Politico
BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader - Finviz
Eli Lilly’s Strategic Moves in the Weight-Loss Drug Arena - AD HOC NEWS
Eli Lilly Partners with Nvidia to Invest $1 Billion in AI Drug Discovery - Intellectia AI
Eli Lilly: A Strong Player in the Pharmaceutical Arena - The Motley Fool
Eli Lilly stock: FDA pushes orforglipron decision to April 10 as lawsuit adds another overhang - TechStock²
Chai Discovery and Eli Lilly Partner to Accelerate AI-Driven Drug Development - Букви
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development - TechCrunch
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? - The Motley Fool
Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly - Reuters
Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica - GlobeNewswire Inc.
LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling - Yahoo Finance Singapore
Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. - The Motley Fool
NVIDIA and Lilly launch $1B AI lab for drug discovery ... - eeNews Europe
Rakuten Securities Inc. Boosts Stock Position in Eli Lilly and Company $LLY - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Has $15.61 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab for Drug Development - HLTH
Eli Lilly stock slides premarket after FDA sets April 10 target for weight-loss pill decision, GLP-1 lawsuit filed - TechStock²
Forbes J M & Co. LLP Acquires 3,186 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Holdings Reduced by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Blalock Williams LLC Buys New Position in Eli Lilly and Company $LLY - MarketBeat
[JPM 2026] ABL Bio seeks next license-out after GSK, Eli Lilly deals - theinvestor.co.kr
Regulatory Hurdles and Legal Challenge Weigh on Eli Lilly Shares - AD HOC NEWS
Eli Lilly stock slides after FDA pushes obesity pill decision to April 10 - TechStock²
Lobbying Update: $2,200,000 of ELI LILLY AND COMPANY lobbying was just disclosed - Quiver Quantitative
IU and Eli Lilly team up to study impact of GLP-1 drugs in workplace - WRTV
Eli Lilly and Novo Nordisk Accused of Blocking Access to Lower-Cost Weight-Loss Drugs - PYMNTS.com
Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers - Benzinga
Why Eli Lilly (LLY) Stock Is Down Today - Finviz
Eli Lilly (LLY) Faces Potential Delay in Weight Loss Pill Approval - GuruFocus
Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers - Stocktwits
Eli Lilly drops as FDA decision on weight loss pill is now expected in April - Seeking Alpha
JPM: NVIDIA and Eli Lilly announce co-innovation AI lab - MobiHealthNews
Where is Eli Lilly and Company (LLY) Headed According to Analysts? - Insider Monkey
Nvidia and Lilly to create AI co-innovation lab - The Pharma Letter
Eli Lilly Stock (LLY) Falls 5% After FDA Delays Decision on Weight-Loss Pill - TipRanks
Eli Lilly and Co (LLY) Shares Down 4.92% on Jan 15 - GuruFocus
Eli Lilly (LLY) Stock Dips Amid FDA Review Delay on Weight-Loss Pill - GuruFocus
Eli Lilly slips in pre-market! New pill still under FDA scrutiny 💊 - XTB.com
AMD, Eli Lilly among market cap stock movers on Thursday - Investing.com
Lilly, Novo sued over GLP‑1 drug dominance by compounding pharmacy - Reuters
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent - PharmaLive
JPM26: Eli Lilly highlights Lp(a) drugs as cardiovascular growth focus - Clinical Trials Arena
Eli Lilly and Company Stock (LLY) Opinions on Obesity Drug Partnership and AI Investment - Quiver Quantitative
JPM26: Eli Lilly’s obesity drugs target commercial and governmental access - Pharmaceutical Technology
WealthPLAN Partners LLC Grows Position in Eli Lilly and Company $LLY - MarketBeat
WealthPlan Investment Management LLC Has $1.56 Million Stake in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly shares dip as FDA delays decision on weight-loss pill - Investing.com
2,142 Shares in Eli Lilly and Company $LLY Bought by Touchstone Capital Inc. - MarketBeat
The Truth About Eli Lilly: Is Wall Street’s Favorite Pharma Stock Still Worth the Hype? - AD HOC NEWS
Eli Lilly’s Dual Strategy: AI Innovation and Weight-Loss Pipeline Drive Investor Confidence - AD HOC NEWS
Retirement Planning Group LLC Has $1.14 Million Stake in Eli Lilly and Company $LLY - MarketBeat
NVIDIA and Eli Lilly Target AI Medicine Manufacturing - Healthcare Digital
Arcadia Investment Management Corp MI Purchases 1,995 Shares of Eli Lilly and Company $LLY - MarketBeat
Ashton Thomas Securities LLC Takes Position in Eli Lilly and Company $LLY - MarketBeat
Compounding Pharmacy Accuses Eli Lilly, Novo Nordisk of Blocking GLP-1 Competition - USA Herald
Eli Lilly’s Strategic Moves: FDA Timeline, AI Partnership, and Legal Hurdles - AD HOC NEWS
Eli Lilly, Novo Hit With Antitrust Suit From Drug Compounder (1) - Bloomberg Law News
Eli Lilly (LLY) and Novo Nordisk Face Legal Battle Over GLP-1 Dr - GuruFocus
Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition - Seeking Alpha
Eli Lilly’s Next Strategic Move: An Oral Contender for the Weight-Loss Market - AD HOC NEWS
Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk - PR Newswire
Behind the Scenes of Eli Lilly and Co's Latest Options TrendsEli Lilly and Co (NYSE:LLY) - Benzinga
NVIDIA and Eli Lilly Launch $1B AI Co-Innovation Lab to Reinvent Drug Discovery - Oncodaily
0.41%
9.12%
자본화:
|
볼륨(24시간):